Arrhythmia/EP
Box-lesion set during modified Cox maze significantly improves patient outcomes
April 11, 2008 | Michael O'Riordan

St Louis, MO - Placing an additional ablation set during the Cox-maze procedure, a short step that adds between 10 and 20 seconds to surgery performed to treat atrial fibrillation, significantly improves clinical outcomes, according to a new report [1]. Isolating the entire posterior left atrium by creating a "box lesion" resulted in a significantly lower incidence of early atrial arrhythmias and higher freedom from atrial fibrillation at one and three months, say investigators.

Publishing the findings in the April issue of the Journal of Thoracic and Cardiovascular Surgery, lead investigator Dr Rochus Voeller (Washington University School of Medicine, St Louis, MO), along with senior author Dr Ralph Damiano, explain that the box lesion is created by making an additional ablation line across the dome of the left atrium between the superior right and left pulmonary veins. This surrounds and isolates the pulmonary veins and the posterior left atrial wall from the rest of the left atrium.

First introduced into clinical practice in 1987, the Cox-maze procedure has been modified over the years, with Damiano and colleagues replacing the surgical incisions with linear lines of ablation on the atria. Initially, the authors note, the right and left pulmonary vein lesions were connected inferiorly with a single ablation line, leaving the "posterior left atrium in electrical continuity with the remaining atrium."

To test the effect of completely isolating the posterior left atrium with the box lesion, the group investigated the difference in outcomes between patients who underwent the Cox-maze procedure with or without the additional box-lesion set in the posterior left atrium. From April 2002 to September 2006, 137 patients underwent a bipolar radiofrequency ablation-assisted Cox-maze procedure at Barnes-Jewish Hospital in St Louis.

Overall, freedom from atrial fibrillation recurrence at one and three months was significantly higher among those who received the box-lesion set. By six and 12 months, all patients who received the box-lesion set were free from atrial fibrillation, report the authors. The use of antiarrhythmic drugs was also significantly lower among those who had their pulmonary veins and the posterior left atrial wall electrically isolated from the rest of the left atrium with the box-lesion set.

Results comparing box-lesion set with single bipolar ablation lesion

End point
Box-lesion set, n=81 (%)
Single connecting ablation lesion, n=56 (%)
p
Freedom from atrial fibrillation recurrence at 1 mo
87
69
0.015
Freedom from atrial fibrillation recurrence at 3 mo
96
85
0.028
Use of antiarrhythmic drugs at 3 mo
35
58
0.018
Use of antiarrhythmic drugs at 6 mo
15
44
0.002

To download table as a slide, click on slide logo below

"The most dramatic finding of this study was that isolating the entire posterior left atrium instead of only the individual pulmonary veins during the Cox-maze IV procedure resulted in a significant decrease in the incidence of early postoperative atrial tachyarrhythmia. The incidence was decreased by 48%," write Voeller and colleagues. "This likely was the reason for the shorter median length of hospital stay in the box-lesion group, because the management was simplified without the occurrence of postoperative atrial tachyarrhythmias."

Source
  1. Voeller RK, Bailey MS, Zierer A, et al. Isolating the entire posterior left atrium improves surgical outcomes after the Cox maze procedure. J Thorac Cardiovasc Surg 2008; 135:870-877.




You have to be logged in to add a comment to this article
Login
Username 
Password 
  Forgot your password?
 
Remember me on this computer
 
Register
Click on "register" to create a account - It is free....
 
button
Previews
Featured CME
Inside: Arrhythmia/EP
Arrhythmia/EP
May 27, 2008 11:30 EDT
Drs Lindsay, Brugada, Gold and Stein highlight the most recent clinical trial data demonstrating the efficacy and safety of ICDs and cardiac resynchronization therapy (CRT) devices and their potential impact on clinical practice.
Arrhythmia/EP
Sep 27, 2007 10:00 EDT
In this program, critical aspects of remote monitoring will be discussed using case studies and active audience participation. It will highlight and evaluate present and future strategies in the identification and treatment of patients with heart failure, with special emphasis on the development of a clinical consensus that will help guide physicians to successfully meet the challenges of heart failure patient management. With Drs Silver, Ewald, Horstmanshof, Semigran and Mary Orencole MS, APRN.
Arrhythmia/EP
Jun 3, 2008 10:56 EDT
In the ATHENA trial, an investigational amiodarone congener prolonged time to first CV hospitalization or death in elderly AF patients. The electrophysiologists have had their say what are the implications for the rest of the cardiology community? Hear Drs Alpert, Steg and Topol give the non-EP perspective.
Arrhythmia/EP
May 19, 2008 12:20 EDT
The ATHENA trial was a late-breaker at Heart Rhythm 2008. Join Drs Prystowsky, Hohnloser, Ruskin and Waldo as they discuss pharmacologic challenges in AF management.